Sandeep Saggar

Sandeep Saggar is a seasoned finance and planning executive with a wealth of experience in managing strategic, financial, and forecasting functions within the biopharma industry.

He has a proven track record of creating and implementing innovative solutions to achieve tangible results, showcasing his persistent nature, keen sense of urgency, and results-driven focus.

Sandeep's skill set is a blend of analytical prowess, organizational acumen, and strong interpersonal abilities, making him a multifaceted professional in his field.

He pursued his education at reputable institutions, earning an MBA in General Management with a focus on Finance from the University of Virginia's Darden Graduate School of Business Administration.

Additionally, Sandeep holds a Master's degree in Chemistry from The College of William and Mary, complemented by a Bachelor's degree in Chemistry from William & Mary.

Sandeep Saggar's career boasts an impressive array of roles in leading pharmaceutical companies, including his current position as Director of Global Commercial Finance for the Hematology and Solid Tumor Franchises at Novartis Oncology.

Prior to his role at Novartis, Sandeep held pivotal positions at Pfizer, where he served as the Commercial Finance, PIH FP&A Lead for Oncology and Vaccines, Senior Finance Manager for the Oncology Business Unit, and Finance Manager for various business units.

His earlier roles at Pfizer encompassed responsibilities such as Business Analysis in the Oncology and Established Products Business Units, Operations Planning & Analysis, Corporate Treasury, and Global Manufacturing.

Before his tenure at Pfizer, Sandeep gained valuable experience as a Research Chemist in the Department of Medicinal Chemistry at Merck & Co., Inc., further enriching his expertise in the pharmaceutical sector.